INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Northrop Grumman Corporation - NOC

12.05.25 23:32 Uhr

Werte in diesem Artikel

NEW YORK, May 12, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Northrop Grumman Corporation ("Northrop Grumman" or the "Company") (NYSE: NOC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Fighting for victims of securities fraud for more than 85 years (PRNewsfoto/Pomerantz LLP)

The investigation concerns whether Northrop Grumman and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action] 

On April 22, 2025, Northrop Grumman issued a press release announcing its financial results for the first quarter of 2025.  Among other items, Northrop Grumman reported revenue of $9.47 billion, representing a 7% year-over-year decline and missing consensus estimates by $480 million.  The Company's results included a charge of $477 million pretax tied to manufacturing updates related to its B-21 bomber program.  On a related earnings call, Northrop Grumman's Chief Executive Officer attributed the "charges on the [B-21 bomber] program" largely to "inflationary factors[.]" 

On this news, Northrop Grumman's stock price fell $67.25 per share, or 12.66%, to close at $464.08 per share on April 22, 2025.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes.  

CONTACT:
Danielle Peyton
Pomerantz LLP
dpeyton@pomlaw.com
646-581-9980 ext. 7980

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-northrop-grumman-corporation---noc-302452876.html

SOURCE Pomerantz LLP

In eigener Sache

Übrigens: Northrop Grumman und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Northrop Grumman

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Northrop Grumman

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Northrop Grumman Corp.

Wer­bung

Analysen zu Northrop Grumman Corp.

DatumRatingAnalyst
29.03.2018Northrop Grumman OverweightBarclays Capital
26.10.2017Northrop Grumman OutperformRBC Capital Markets
12.01.2017Northrop Grumman OutperformRBC Capital Markets
10.11.2016Northrop Grumman OverweightBarclays Capital
06.10.2016Northrop Grumman OutperformRobert W. Baird & Co. Incorporated
DatumRatingAnalyst
29.03.2018Northrop Grumman OverweightBarclays Capital
26.10.2017Northrop Grumman OutperformRBC Capital Markets
12.01.2017Northrop Grumman OutperformRBC Capital Markets
10.11.2016Northrop Grumman OverweightBarclays Capital
06.10.2016Northrop Grumman OutperformRobert W. Baird & Co. Incorporated
DatumRatingAnalyst
19.05.2016Northrop Grumman Sector PerformRBC Capital Markets
02.05.2016Northrop Grumman Equal WeightBarclays Capital
30.04.2015Northrop Grumman NeutralUBS AG
12.02.2015Northrop Grumman Equal WeightBarclays Capital
19.10.2012Northrop Grumman performOppenheimer & Co. Inc.
DatumRatingAnalyst
13.09.2012Northrop Grumman sellUBS AG
14.06.2006Update Northrop Grumman Corp.: UnderperformGoldman Sachs

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Northrop Grumman Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen